P217 Salford lung study chronic obstructive pulmonary disease follow-up interviews: analyses by treatment comparisons and exacerbations

The Salford Lung Study in Chronic Obstructive Pulmonary Disease (SLS COPD) compared the initiation of once-daily fluticasone furoate/vilanterol 100/25 μg (FF/VI) treatment versus continuation of usual care (UC). The annual rate of moderate or severe exacerbations was significantly lower for patients initiated on FF/VI compared with UC (Vestbo, NEJM 2016). We conducted a follow-up study to compare the experiences of patients completing SLS COPD, b y exacerbation rate and randomized treatment.

Source: Annals of Allergy, Asthma and Immunology - October 27, 2017 Category: Allergy & Immunology Authors: D. Whalley, H. Svedsater, L. Doward, R. Crawford, D. Leather, J. Lay-Flurrie, N. Bosanquet Source Type: research